Co-Authors
This is a "connection" page, showing publications co-authored by Marco Merli and Massimo Puoti.
Connection Strength
4.775
-
Mild Course of SARS-CoV-2 Infection in a Liver Transplant Recipient Undergoing Plasma Exchange and Defibrotide for Acute Graft Rejection. Transplantation. 2021 02 01; 105(2):e22-e24.
Score: 0.927
-
Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients. J Infect. 2021 03; 82(3):414-451.
Score: 0.910
-
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic. Liver Transpl. 2020 11; 26(11):1543-1544.
Score: 0.900
-
Hepatitis A Virus in men who have sex with men: Need for awareness and vaccination. Liver Int. 2018 04; 38(4):581-584.
Score: 0.761
-
Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experience. Am J Transplant. 2020 09; 20(9):2628-2629.
Score: 0.222
-
Severe cholestatic hepatitis related to abacavir/lamivudine/dolutegravir antiretroviral treatment in a HIV-1 infected subject. AIDS. 2018 07 31; 32(12):1727-1729.
Score: 0.195
-
Feasibility of all-oral anti-HCV treatment during DHAP chemotherapy and autologous stem cell transplantation for T-cell lymphoma. New Microbiol. 2018 07; 41(3):242-245.
Score: 0.191
-
COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study. Gut. 2021 10; 70(10):1914-1924.
Score: 0.060
-
Neurological manifestations in patients hospitalized with COVID-19: A retrospective analysis from a large cohort in Northern Italy. Eur J Neurosci. 2021 04; 53(8):2912-2922.
Score: 0.059
-
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study. BMC Infect Dis. 2021 Feb 17; 21(1):184.
Score: 0.058
-
Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy. PLoS One. 2020; 15(11):e0242765.
Score: 0.057
-
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study. Clin Microbiol Infect. 2021 Jan; 27(1):105-111.
Score: 0.057
-
Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients. PLoS One. 2020; 15(9):e0236311.
Score: 0.056
-
Does interval time between liver transplant and COVID-19 infection make the difference? Dig Liver Dis. 2021 02; 53(2):169-170.
Score: 0.056
-
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study). Clin Microbiol Infect. 2020 Nov; 26(11):1545-1553.
Score: 0.056
-
Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis. J Infect. 2020 10; 81(4):e11-e17.
Score: 0.056
-
Successful recovery from severe COVID-19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumab. Transpl Infect Dis. 2020 Oct; 22(5):e13334.
Score: 0.055
-
The impact of HIV infection and men who have sex with men status on hepatitis A infection: The experience of two tertiary centres in Northern Italy during the 2017 outbreak and in the 2009-2016 period. J Viral Hepat. 2019 06; 26(6):761-765.
Score: 0.051
-
HIV-positive to HIV-positive liver transplantation: To be continued. J Hepatol. 2019 04; 70(4):788-789.
Score: 0.049